These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 38819751)

  • 21. Cardiovascular Morbidity and Mortality in Primary Sjögren's Syndrome: A Systematic Review and Meta-Analysis.
    Beltai A; Barnetche T; Daien C; Lukas C; Gaujoux-Viala C; Combe B; Morel J
    Arthritis Care Res (Hoboken); 2020 Jan; 72(1):131-139. PubMed ID: 30570824
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Predictive Utility of Cardiovascular Risk Prediction Algorithms in Inflammatory Rheumatic Diseases: A Systematic Review.
    Colaco K; Ocampo V; Ayala AP; Harvey P; Gladman DD; Piguet V; Eder L
    J Rheumatol; 2020 Jun; 47(6):928-938. PubMed ID: 31416923
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Metabolic Syndrome and Its Components Have a Different Presentation and Impact as Cardiovascular Risk Factors in Psoriatic and Rheumatoid Arthritis.
    Atzeni F; La Corte L; Cirillo M; Giallanza M; Galloway J; Rodríguez-Carrio J
    J Clin Med; 2023 Jul; 12(15):. PubMed ID: 37568433
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Biosemantics guided gene expression profiling of Sjögren's syndrome: a comparative analysis with systemic lupus erythematosus and rheumatoid arthritis.
    Shah NR; Noll BD; Stevens CB; Brennan MT; Mougeot FB; Mougeot JC
    Arthritis Res Ther; 2017 Aug; 19(1):192. PubMed ID: 28818099
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Temporomandibular disorders in immune-mediated rheumatic diseases of the adult: A systematic review.
    Hysa E; Lercara A; Cere A; Gotelli E; Gerli V; Paolino S; Pizzorni C; Sulli A; Smith V; Cutolo M
    Semin Arthritis Rheum; 2023 Aug; 61():152215. PubMed ID: 37167773
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Higher odds of periodontitis in systemic lupus erythematosus compared to controls and rheumatoid arthritis: a systematic review, meta-analysis and network meta-analysis.
    Tan PR; Lee AJL; Zhao JJ; Chan YH; Fu JH; Ma M; Tay SH
    Front Immunol; 2024; 15():1356714. PubMed ID: 38629069
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Association between baseline cardiovascular risk and incidence rates of major adverse cardiovascular events and malignancies in patients with psoriatic arthritis and psoriasis receiving tofacitinib.
    Kristensen LE; Strober B; Poddubnyy D; Leung YY; Jo H; Kwok K; Vranic I; Fleishaker DL; Fallon L; Yndestad A; Gladman DD
    Ther Adv Musculoskelet Dis; 2023; 15():1759720X221149965. PubMed ID: 36777695
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Higher Incidence Rates of Comorbidities in Patients with Psoriatic Arthritis Compared with the General Population Using U.S. Administrative Claims Data.
    Kaine J; Song X; Kim G; Hur P; Palmer JB
    J Manag Care Spec Pharm; 2019 Jan; 25(1):122-132. PubMed ID: 29694270
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Psychiatric manifestations of lupus erythematosus systemic and Sjogren's syndrome].
    Ampélas JF; Wattiaux MJ; Van Amerongen AP
    Encephale; 2001; 27(6):588-99. PubMed ID: 11865567
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Subclinical atherosclerosis in patients with systemic lupus erythematosus: A systemic review and meta-analysis.
    Wu GC; Liu HR; Leng RX; Li XP; Li XM; Pan HF; Ye DQ
    Autoimmun Rev; 2016 Jan; 15(1):22-37. PubMed ID: 26455562
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Traditional and disease-related non-computed variables affect algorithms for cardiovascular risk estimation in Sjögren's syndrome and rheumatoid arthritis.
    Cafaro G; Perricone C; Riccucci I; Bursi R; Calvacchi S; Alunno A; Carubbi F; Gerli R; Bartoloni E
    Clin Exp Rheumatol; 2021; 39 Suppl 133(6):107-113. PubMed ID: 34665709
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The Biological Disease-Modifying Antirheumatic Drugs and the Risk of Cardiovascular Events: A Systematic Review and Meta-Analysis.
    Hu S; Lin C; Cai X; Zhu X; Lv F; Nie L; Ji L
    Mediators Inflamm; 2021; 2021():7712587. PubMed ID: 34504395
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Systematic review and meta-analysis on prevalence of metabolic syndrome in psoriatic arthritis, rheumatoid arthritis and psoriasis.
    Loganathan A; Kamalaraj N; El-Haddad C; Pile K
    Int J Rheum Dis; 2021 Sep; 24(9):1112-1120. PubMed ID: 34076348
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Simultaneous double arm automated blood pressure measurement for the screening of subjects with potential vascular disease: a community study.
    Omboni S; Verberk WJ
    Blood Press; 2019 Feb; 28(1):15-22. PubMed ID: 30460865
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of Secukinumab on Traditional Cardiovascular Risk Factors and Inflammatory Biomarkers: Post Hoc Analyses of Pooled Data Across Three Indications.
    Merola JF; McInnes IB; Deodhar AA; Dey AK; Adamstein NH; Quebe-Fehling E; Aassi M; Peine M; Mehta NN
    Rheumatol Ther; 2022 Jun; 9(3):935-955. PubMed ID: 35305260
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Systematic review and meta-analysis of the epidemiology of polyautoimmunity in Sjögren's syndrome (secondary Sjögren's syndrome) focusing on autoimmune rheumatic diseases.
    Alani H; Henty JR; Thompson NL; Jury E; Ciurtin C
    Scand J Rheumatol; 2018 Mar; 47(2):141-154. PubMed ID: 28927315
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Association between biologic therapy and fracture incidence in patients with selected rheumatic and autoimmune diseases: A systematic review and meta-analysis of randomized controlled trials.
    Lv F; Hu S; Lin C; Cai X; Zhu X; Ji L
    Pharmacol Res; 2022 Jul; 181():106278. PubMed ID: 35644324
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Coronary calcium in autoimmune diseases: A systematic literature review and meta-analysis.
    Martínez-Ceballos MA; Sinning Rey JC; Alzate-Granados JP; Mendoza-Pinto C; García-Carrasco M; Montes-Zabala L; Vargas-Vergara D; Munguia-Realpozo P; Etchegaray-Morales I; Rojas-Villarraga A
    Atherosclerosis; 2021 Oct; 335():68-76. PubMed ID: 34592584
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Usefulness of CHA
    Cioffi G; Viapiana O; Orsolini G; Idolazzi L; Fracassi E; Ognibeni F; Dalbeni A; Gatti D; Carletto A; Fassio A; Rossini M; Giollo A
    Int J Rheum Dis; 2020 Jan; 23(1):106-115. PubMed ID: 31854508
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The effects of tumour necrosis factor inhibitors, methotrexate, non-steroidal anti-inflammatory drugs and corticosteroids on cardiovascular events in rheumatoid arthritis, psoriasis and psoriatic arthritis: a systematic review and meta-analysis.
    Roubille C; Richer V; Starnino T; McCourt C; McFarlane A; Fleming P; Siu S; Kraft J; Lynde C; Pope J; Gulliver W; Keeling S; Dutz J; Bessette L; Bissonnette R; Haraoui B
    Ann Rheum Dis; 2015 Mar; 74(3):480-9. PubMed ID: 25561362
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.